Skip to main content
. 2022 May 9;2(5):330–341. doi: 10.1158/2767-9764.CRC-22-0083

FIGURE 3.

FIGURE 3

BCMA expression on different B-cell malignancies. A and B, IHC of paraffin-embedded slides of different B-cell malignancies at 400× magnification. A, Tumor cells were identified per disease type based on staining of Pax-5 for CLL (n = 4) and DLBCL (n = 3), IgM for LPL (n = 3), cyclin D1 for MCL (n = 3), and CD138 for multiple myeloma (MM; n = 4). B, Examples of strong, moderate, weak, and no expression of BCMA by IHC both on membrane and golgi.